Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
38%(3 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
3
33%
Ph phase_2
6
67%

Phase Distribution

3

Early Stage

6

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
6(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Terminated(1)

Detailed Status

Completed8
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (33.3%)
Phase 26 (66.7%)

Trials by Status

completed889%
terminated111%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_2

Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

NCT01424397
terminatedphase_2

Sb-705498 Rectal Pain Study

NCT00461682
completedphase_2

SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis

NCT01424514
completedphase_1

A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model

NCT00731250
completedphase_1

Intranasal SB-705498 in Healthy Volunteers

NCT00907933
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT01424397Phase 2

Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

Completed
NCT00461682Phase 2

Sb-705498 Rectal Pain Study

Terminated
NCT01424514Phase 2

SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis

Completed
NCT00731250Phase 1

A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model

Completed
NCT00907933Phase 1

Intranasal SB-705498 in Healthy Volunteers

Completed
NCT01673529Phase 1

Investigation of Topical SB705498 on Healthy Volunteers

Completed
NCT01439308Phase 2

Intranasal SB-705498 in Non-allergic Rhinitis Patients

Completed
NCT01476098Phase 2

A Study to Investigate the Effect of SB-705498 on Chronic Cough

Completed
NCT00269022Phase 2

Use Of SB-705498 In The Acute Treatment Of Migraine

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9